Healthcare Industry Trends
Q1 2023 Update

Download the report

Key takeaways

During this downturn, healthcare and life science companies have faced unique challenges such as pressure to hit clinical, operational and strategic milestones sooner. Additionally, exits fell sharply in 2022 and haven’t recovered as public markets remain muted in 2023. Yet, there are signs of optimism with early-stage valuations and investment bolstered by strong investor interest.


Venture capital raised since 2021. Sitting on record dry powder, VCs are well-positioned to fund new healthcare companies.


Funds closed in Q1 2023, signaling that overall interest in healthcare investment remains strong.


The number of US VC deals in Q1 2023 held steady as investors focused on their portfolio companies.